EVOQ Therapeutics
Company Details
Status: Private
Employees: 1-10
Location:
Ann Arbor, Michigan
Type:
sample
sample
Technology:
sample
sample
About: EVOQ Therapeutics is developing immunotherapies to improve the lives of individuals fighting autoimmune diseases.
There are more than 100 chronic autoimmune diseases - many severely debilitating, and some life-threatening. According to the National Institutes of Health, up to 23.5 million Americans (over 7% of the population) suffer from autoimmune disease, and the prevalence is rising.
Autoimmune disease occurs when the body’s central immune tolerance system fails - resulting in T and B cell-mediated destruction of self-tissues. This immune system failure is responsible for many devastating diseases including – Type 1 Diabetes, Celiac disease, Multiple sclerosis and Rheumatoid Arthritis.
EVOQ’s technology unleashes and restores the body’s natural immune tolerance pathways.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
EVOQ Therapeutics | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.